208 related articles for article (PubMed ID: 11309343)
1. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
Airley R; Loncaster J; Davidson S; Bromley M; Roberts S; Patterson A; Hunter R; Stratford I; West C
Clin Cancer Res; 2001 Apr; 7(4):928-34. PubMed ID: 11309343
[TBL] [Abstract][Full Text] [Related]
2. Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers.
Mayer A; Höckel M; Wree A; Vaupel P
Clin Cancer Res; 2005 Apr; 11(7):2768-73. PubMed ID: 15814659
[TBL] [Abstract][Full Text] [Related]
3. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
Airley RE; Loncaster J; Raleigh JA; Harris AL; Davidson SE; Hunter RD; West CM; Stratford IJ
Int J Cancer; 2003 Mar; 104(1):85-91. PubMed ID: 12532423
[TBL] [Abstract][Full Text] [Related]
4. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
Hutchison GJ; Valentine HR; Loncaster JA; Davidson SE; Hunter RD; Roberts SA; Harris AL; Stratford IJ; Price PM; West CM
Clin Cancer Res; 2004 Dec; 10(24):8405-12. PubMed ID: 15623619
[TBL] [Abstract][Full Text] [Related]
7. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
Yen TC; See LC; Lai CH; Yah-Huei CW; Ng KK; Ma SY; Lin WJ; Chen JT; Chen WJ; Lai CR; Hsueh S
J Nucl Med; 2004 Jan; 45(1):22-9. PubMed ID: 14734665
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas.
Hedley D; Pintilie M; Woo J; Morrison A; Birle D; Fyles A; Milosevic M; Hill R
Clin Cancer Res; 2003 Nov; 9(15):5666-74. PubMed ID: 14654550
[TBL] [Abstract][Full Text] [Related]
10. Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking?
Mayer A; Höckel M; Vaupel P
Strahlenther Onkol; 2006 Sep; 182(9):501-10. PubMed ID: 16944371
[TBL] [Abstract][Full Text] [Related]
11. A clinical study of hypoxia using endogenous hypoxic markers and polarographic oxygen electrodes.
Sakata K; Someya M; Nagakura H; Nakata K; Oouchi A; Hareyama M; Satoh M
Strahlenther Onkol; 2006 Sep; 182(9):511-7. PubMed ID: 16944372
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
Airley RE; Mobasheri A
Chemotherapy; 2007; 53(4):233-56. PubMed ID: 17595539
[TBL] [Abstract][Full Text] [Related]
14. Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?
Cooper R; Sarioğlu S; Sökmen S; Füzün M; Küpelioğlu A; Valentine H; Görken IB; Airley R; West C
Br J Cancer; 2003 Sep; 89(5):870-6. PubMed ID: 12942120
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study of the expression of the hypoxia markers Glut-1 and Ca-IX in canine sarcomas.
Abbondati E; Del-Pozo J; Hoather TM; Constantino-Casas F; Dobson JM
Vet Pathol; 2013 Nov; 50(6):1063-9. PubMed ID: 23628694
[TBL] [Abstract][Full Text] [Related]
16. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(5):2635-9. PubMed ID: 12529975
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
[TBL] [Abstract][Full Text] [Related]
18. Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.
Evans A; Bates V; Troy H; Hewitt S; Holbeck S; Chung YL; Phillips R; Stubbs M; Griffiths J; Airley R
Cancer Chemother Pharmacol; 2008 Mar; 61(3):377-93. PubMed ID: 17520257
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
20. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Anticancer Res; 2003; 23(4):3263-72. PubMed ID: 12926062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
